Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5479286 | 0.82 | ALDH1A1 (0.38) | ALDH1A1POLBMAPT | |
| SCHEMBL27628887 | 0.79 | MAPT (0.38) | ALDH1A1POLBMAPT | |
| SCHEMBL301397 | 0.74 | ALDH1A1 (0.35) | ALDH1A1POLBMAPT | |
| SCHEMBL7632015 | 0.73 | GRM8 (0.36) | ALDH1A1POLBMAPTGRM8GRM4 | |
| SCHEMBL14861413 | 0.72 | BRD4 (0.32) | ALDH1A1POLBMAPT | |
| SCHEMBL2976953 | 0.71 | ALDH1A1 (0.33) | ALDH1A1POLBMAPT | |
| SCHEMBL27989702 | 0.71 | BRD4 (0.32) | ALDH1A1POLBMAPT | |
| SCHEMBL28132698 | 0.69 | MAP2K1 (0.35) | ALDH1A1POLBMAPT | |
| SCHEMBL8943286 | 0.69 | TP53 (0.35) | ALDH1A1POLBMAPT | |
| SCHEMBL6537411 | 0.69 | KMO (0.36) | ALDH1A1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 374 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735029-A2 | MULTIVALENT INFLUENZA MRNA VACCINES | Sanofi Vaccines US Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20250340937-A1 | COLORECTAL CANCER ASSOCIATED CIRCULATING NUCLEIC ACID BIOMARKERS | CHRONIX BIOMEDICAL (US) | 2025-11-06 | — | — | US | disclosed |
| EP-4622630-A1 | COMPOSITIONS OF DRY POWDER FORMULATIONS OF MESSENGER RNA AND METHODS OF USE THEREOF | Translate Bio, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| US-12359252-B2 | Colorectal cancer associated circulating nucleic acid biomarkers | CHRONIX BIOMEDICAL (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250171764-A1 | PURIFICATION OF NUCLEIC ACIDS USING COPPER-TITANIUM OXIDES | ABBOTT MOLECULAR INC. | 2025-05-29 | — | — | US | disclosed |
| EP-4555102-A1 | SCALABLE, SUBMICRON-RESOLUTION REPLICATION OF DNA ARRAYS | Topogene Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025003756-A2 | MULTIVALENT INFLUENZA MRNA VACCINES | SANOFI (FR) | 2025-01-02 | — | — | WO | disclosed |
| US-20240401120-A1 | METHODS FOR BIAS-FREE QUANTIFICATION OF RNA | CHRONIX BIOMEDICAL (US) | 2024-12-05 | — | — | US | disclosed |
| EP-4409031-A1 | METHODS FOR BIAS-FREE QUANTIFICATION OF RNA | Chronix Biomedical (US) | 2024-08-07 | — | — | EP | disclosed |
| WO-2024112652-A1 | COMPOSITIONS OF DRY POWDER FORMULATIONS OF MESSENGER RNA AND METHODS OF USE THEREOF | TRANSLATE BIO, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| EP-0789707-A4 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1999-02-24 | — | — | EP | disclosed |
| WO-1998039431-A1 | SR-BI REGULATORY SEQUENCES AND THERAPEUTIC METHODS OF USE | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1998-09-11 | — | — | WO | disclosed |
| WO-1998036065-A1 | DIFFERENTIATION ENHANCING FACTORS AND USES THEREFOR | DANA-FARBER CANCER INSTITUTE (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998017688-A1 | OSTEOMETRIN RELATED PEPTIDES AND NUCLEIC ACIDS AND DIAGNOSIS AND THERAPIES USING THEM | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1998-04-30 | — | — | WO | disclosed |
| EP-0789707-A1 | AMINO ACID NUCLEIC ACIDS | ICN PHARMACEUTICALS (US) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996014330-A1 | AMINO ACID NUCLEIC ACIDS | ICNPHARMACEUTICALS (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1995011911-A1 | BINDING COMPETENT OLIGOMERS CONTAINING UNSATURATED 3',5' AND 2',5' LINKAGES | GLAXO WELLCOME INC. (US) | 1995-05-04 | — | — | WO | disclosed |
| EP-0616612-A4 | NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE. | GILEAD SCIENCES INC (US) | 1995-01-11 | — | — | EP | disclosed |
| EP-0616612-A1 | NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE | GILEAD SCIENCES, INC. (US) | 1994-09-28 | — | — | EP | disclosed |
| WO-1993012135-A1 | NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE | GILEAD SCIENCES, INC. (US) | 1993-06-24 | — | — | WO | disclosed |